ICD-10-CM Diagnosis Code (2025)
Official Description for D68.318
Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
Coding Notes & Guidelines for D68.318
- Antithromboplastinemia
- Antithromboplastinogenemia
- Hemorrhagic disorder due to intrinsic increase in antithrombin
- Hemorrhagic disorder due to intrinsic increase in anti-VIIIa
- Hemorrhagic disorder due to intrinsic increase in anti-IXa
- Hemorrhagic disorder due to intrinsic increase in anti-XIa
Parent Code (Less Specific):
About ICD-10-CM Code D68.318 (Other hemorrhagic disorder due to intrinsic circulating anticoagulants)
ICD-10-CM code D68.318 is a billable or specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2025 edition of ICD-10-CM D68.318 became effective on October 1, 2024.
This page provides detailed information about D68.318 - Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors. It includes common terminology, coding guidelines such as "Includes," "Excludes1," and "Excludes2" notes, and information on required 7th characters. Utilizing this information correctly is essential for accurate medical coding and claims submission for conditions like Other hemorrhagic disorder due to intrinsic circulating anticoagulants related to antibodies, or inhibitors.